We confirmed elevation of Path and CG1139 protein levels in Ras/Src-tumours in HSD using the Path- and CG1139-specific antibodies26 (Fig. 4i, j, m, n and Supplementary Fig. 5h–k). The gene discussed is SRC; the disease is neoplasm.